SE7810591L - Farmaceutiska kompositioner - Google Patents

Farmaceutiska kompositioner

Info

Publication number
SE7810591L
SE7810591L SE7810591A SE7810591A SE7810591L SE 7810591 L SE7810591 L SE 7810591L SE 7810591 A SE7810591 A SE 7810591A SE 7810591 A SE7810591 A SE 7810591A SE 7810591 L SE7810591 L SE 7810591L
Authority
SE
Sweden
Prior art keywords
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Application number
SE7810591A
Other languages
English (en)
Other versions
SE435899B (sv
Inventor
P J Crowley
Original Assignee
Beecham Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10423254&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE7810591(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Beecham Group Ltd filed Critical Beecham Group Ltd
Publication of SE7810591L publication Critical patent/SE7810591L/sv
Publication of SE435899B publication Critical patent/SE435899B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
SE7810591A 1977-10-11 1978-10-10 Torr farmaceutisk enhetsdoskomposition SE435899B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB4219177 1977-10-11

Publications (2)

Publication Number Publication Date
SE7810591L true SE7810591L (sv) 1979-04-11
SE435899B SE435899B (sv) 1984-10-29

Family

ID=10423254

Family Applications (2)

Application Number Title Priority Date Filing Date
SE7810591A SE435899B (sv) 1977-10-11 1978-10-10 Torr farmaceutisk enhetsdoskomposition
SE8107592A SE451668B (sv) 1977-10-11 1981-12-17 Farmaceutisk komposition innehallande amoxycillintrihydrat, kaliumklavulanat och ett torkmedel i en sluten behallare

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE8107592A SE451668B (sv) 1977-10-11 1981-12-17 Farmaceutisk komposition innehallande amoxycillintrihydrat, kaliumklavulanat och ett torkmedel i en sluten behallare

Country Status (24)

Country Link
US (2) US4441609A (sv)
JP (1) JPS5476831A (sv)
AU (1) AU525089B2 (sv)
BE (1) BE870988A (sv)
CA (1) CA1105385A (sv)
CH (1) CH642258A5 (sv)
DE (1) DE2843318A1 (sv)
FR (1) FR2405711A1 (sv)
GB (1) GB2005538B (sv)
HK (1) HK73785A (sv)
IE (1) IE47450B1 (sv)
IL (1) IL55660A (sv)
IT (1) IT1109273B (sv)
JO (1) JO984B1 (sv)
KE (1) KE3525A (sv)
MT (1) MTP836B (sv)
MY (1) MY8500996A (sv)
NL (1) NL190631B (sv)
NZ (1) NZ188497A (sv)
PL (1) PL210174A1 (sv)
PT (1) PT68600A (sv)
SE (2) SE435899B (sv)
SG (1) SG34985G (sv)
ZA (1) ZA785682B (sv)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ177159A (en) * 1974-04-20 1978-03-06 Beecham Group Ltd Clavulanic acid, salts, esters and preparation thereof from streptomyces clavuligerus: pharmaceutical compositions
YU40452B (en) * 1975-02-07 1986-02-28 Beecham Group Plc Process for the elimination of contaminating impurities from clavulinic acid
DE2964817D1 (en) * 1978-09-06 1983-03-24 Beecham Group Plc Pharmaceutical compositions containing two beta-lactam derivatives
NZ194912A (en) * 1979-10-02 1983-05-31 Beecham Group Ltd 6 -(2-(2'-methylphenoxycarbonyl)-2-thien-3'-ylacetamido)-penicillanic acid and pharmaceutical compositions
NZ198241A (en) * 1980-09-27 1983-12-16 Beecham Group Ltd Tablet containing amoxycillin and potassium clavulanate
US4406887A (en) * 1981-10-13 1983-09-27 Bristol-Myers Company Method for treating resistant bacteria including anaerobes
EP0080862B1 (en) * 1981-12-02 1985-09-25 Beecham Group Plc Pharmaceutical formulation comprising beta-lactam antibiotics
US5743398A (en) * 1984-05-22 1998-04-28 Southpac Trust International, Inc. Floral wrapper utilizing a breathable packaging material
FR2593152B1 (fr) * 1986-01-22 1988-12-23 Adir Conditionnement etanche sous forme de plaquettes alveolaire permettant des echanges gazeux entre les alveoles.
ES2039226T3 (es) * 1986-12-30 1993-09-16 American Cyanamid Company Procedimiento para preparar composiciones que contienen policarbofil.
GB9007143D0 (en) * 1990-03-30 1990-05-30 Beecham Group Plc Veterinary composition
US5814337A (en) * 1992-10-07 1998-09-29 Beecham Group Plc Pharmaceutical formulation
US5643902A (en) * 1990-04-26 1997-07-01 Pfizer Inc. Veterinary treatment
GB9009446D0 (en) * 1990-04-26 1990-06-20 Beecham Group Plc Veterinary composition
GB9109862D0 (en) * 1991-05-08 1991-07-03 Beecham Lab Sa Pharmaceutical formulations
US5861172A (en) * 1991-05-08 1999-01-19 Laboratorios Beecham Sa Pharmaceutical formulations of compacted granulates of β-lactam antibiotics
GB9201639D0 (en) * 1992-01-25 1992-03-11 Smithkline Beecham Plc Pharmaceutical formulations
GB9408117D0 (en) * 1994-04-23 1994-06-15 Smithkline Beecham Corp Pharmaceutical formulations
GB9411626D0 (en) * 1994-06-10 1994-08-03 Smithkline Beecham Plc Package
ATE208333T1 (de) * 1994-08-05 2001-11-15 West Pharm Serv Cornall Ltd Behälter für feuchtickeitsempfindliche stoffe und entsprechendes verfahren zum trocknen und zur reduktion
GB9416599D0 (en) * 1994-08-17 1994-10-12 Smithkline Beecham Plc Pharmaceutical formulation
DZ2028A1 (fr) 1995-05-03 2002-10-23 Smithkline Beecham Plc Médicaments destinés au traitement d'infections bactériennes en pédiatrie.
US20030109503A1 (en) * 1995-06-06 2003-06-12 Smithkline Beecham P.L.C. Pharmaceutical formulations comprising clavulanic acid alone or in combination with other beta-lactam antibiotics
DE69617036T2 (de) * 1995-09-07 2002-07-11 Smithkline Beecham Corp Verwendung einer amoxicillin und clavulanat enthaltenden paediatrischen pharmazeutischen formulierung
AT403375B (de) * 1995-11-15 1998-01-26 Biochemie Gmbh Verfahren zur fällung von alkalisalzen der clavulansäure
ITMI952354A1 (it) * 1995-11-16 1997-05-16 Smithkline Beecham Spa Composizione farmaceutica
AT407701B (de) * 1996-08-12 2001-05-25 Biochemie Gmbh Zur direkttablettierung geeignete mischung, die als wesentliche komponenten amoxicillin-trihydrat und das kaliumsalz der clavulansäure enthält und verfahren zur herstellung dieser mischung
AT407214B (de) * 1996-03-13 2001-01-25 Biochemie Gmbh Verfahren zur herstellung von hilfsstoffefreien agglomeraten aus beta-lactamantibiotika
TWI225402B (en) 1996-03-13 2004-12-21 Biochemie Gmbh Auxiliary-free agglomerates
US6112888A (en) * 1996-06-28 2000-09-05 W. R. Grace & Co.-Conn. Non-reclosable packages containing desiccant matrix
US6180708B1 (en) 1996-06-28 2001-01-30 W. R. Grace & Co.-Conn. Thermoplastic adsorbent compositions containing wax and insulating glass units containing such compositions
GB9616536D0 (en) 1996-08-06 1996-09-25 Quadrant Holdings Cambridge Co-amoxiclav dosage form
US8022095B2 (en) 1996-08-16 2011-09-20 Pozen, Inc. Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
EA002595B1 (ru) * 1997-02-14 2002-06-27 Смитклайн Бичем Лаборатуар Фармасетик Фармацевтический препарат, содержащий амоксициллин и клавуланат, способ его приготовления и гранулят, содержащий амоксициллин и клавуланат
US20030124187A1 (en) * 1997-02-14 2003-07-03 Smithkline Beecham Laboratoires Pharmaceutiques, Pharmaceutical formulations comprising amoxycillin and clavulanate
WO2000025751A2 (en) * 1998-10-30 2000-05-11 Fuisz International Ltd. Improved amoxycillin and clavulanate composition
US6177421B1 (en) 1999-05-04 2001-01-23 Fuisz International Ltd. Amoxicillin and clavulanate composition
IE990159A1 (en) * 1999-02-26 2000-09-20 Fuisz Internat Ltd Storage Stable Amoxycillin and Clavulanate Suspension Composition.
US6294199B1 (en) 1999-04-13 2001-09-25 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising administering amoxycillin
US6878386B1 (en) 1999-04-13 2005-04-12 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
US7250176B1 (en) * 1999-04-13 2007-07-31 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection
US6426342B2 (en) * 1999-08-16 2002-07-30 Revaax Pharmaceuticals, Llc Use of β-lactamase inhibitors as neuroprotectants
NZ517663A (en) * 1999-08-16 2006-02-24 Revaax Pharmaceuticals Llc Neurotherapeutic clavulanate composition and method
SI20411A (sl) * 1999-12-22 2001-06-30 LEK, tovarna farmacevtskih in kemičnih izdelkov, d.d. Vodotopni praški za peroralno raztopino in njihova uporaba
US6905016B2 (en) * 2000-03-14 2005-06-14 Noven Pharmaceuticals, Inc. Packaging system for transdermal drug delivery systems
AT412213B (de) * 2000-05-30 2004-11-25 Sandoz Ag Verfahren zur trocknung von amoxicillin oder amoxicillin-hältigen, oralen, festen pharmazeutischen zusammensetzungen unter verwendung eines gases mit einer definierten gasfeuchte
EP1330236A2 (en) 2000-10-12 2003-07-30 Beecham Pharmaceuticals (Pte) Limited Formulation containing amoxicillin
US6756057B2 (en) 2000-10-12 2004-06-29 Beecham Pharmaceuticals (Pte) Limited Amoxicillin and potassium clavulanate dosage form
EP1541140A1 (en) * 2002-08-12 2005-06-15 Kyowa Hakko Kogyo Co., Ltd. Amino acid-containing chewable
US7341742B2 (en) * 2002-09-30 2008-03-11 L. Perrigo Company Simethicone containing tablet composition and method
MY147756A (en) * 2005-05-25 2013-01-15 Theravance Inc Benzimidazole-carboxamide compounds as 5-ht4 receptor agonists
DE102006007830A1 (de) * 2006-02-17 2007-08-30 Grünenthal GmbH Lagerstabile orale Darreichungsform von Amoxicillin und Clavulansäure
CA2691451C (en) 2007-06-21 2015-03-24 Sara H. Fan Instrument and receptacles for performing processes
JP2011500811A (ja) * 2007-10-26 2011-01-06 レクサン ファーマシューティカルズ インコーポレイテッド クラブラン酸の医薬品製剤
JP2012525427A (ja) * 2009-04-29 2012-10-22 レクサン ファーマシューティカルズ インコーポレイテッド 神経保護および神経変性疾患の治療のためのクラブラン酸塩製剤
TR200909787A2 (tr) 2009-12-25 2011-07-21 Bi̇lgi̇ç Mahmut Üçüncü kuşak bir sefalosporin ve klavulanik asit içeren farmasötik formülasyonlar.
US8652527B1 (en) 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
US9101545B2 (en) * 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3128135A (en) * 1962-05-29 1964-04-07 Anaconda Wire & Cable Co Moisture-free package
US3567085A (en) * 1968-12-02 1971-03-02 James G Flores Neck-supported pill container
NZ177159A (en) * 1974-04-20 1978-03-06 Beecham Group Ltd Clavulanic acid, salts, esters and preparation thereof from streptomyces clavuligerus: pharmaceutical compositions

Also Published As

Publication number Publication date
AU4050678A (en) 1980-04-17
CH642258A5 (de) 1984-04-13
IT7851415A0 (it) 1978-10-09
IT1109273B (it) 1985-12-16
FR2405711B1 (sv) 1982-10-29
MY8500996A (en) 1985-12-31
MTP836B (en) 1979-05-11
DE2843318A1 (de) 1979-04-12
NL7810176A (nl) 1979-04-17
IL55660A (en) 1981-09-13
JPS6341886B2 (sv) 1988-08-19
GB2005538A (en) 1979-04-25
NZ188497A (en) 1981-05-01
IE782019L (en) 1979-04-11
SE435899B (sv) 1984-10-29
GB2005538B (en) 1982-05-26
HK73785A (en) 1985-10-04
PL210174A1 (sv) 1980-08-11
KE3525A (en) 1985-05-31
SE451668B (sv) 1987-10-26
IL55660A0 (en) 1978-12-17
NL190631B (nl) 1994-01-03
US4301149A (en) 1981-11-17
SG34985G (en) 1985-11-15
CA1105385A (en) 1981-07-21
IE47450B1 (en) 1984-03-21
JPS5476831A (en) 1979-06-19
ZA785682B (en) 1979-09-26
JO984B1 (en) 1979-12-01
AU525089B2 (en) 1982-10-21
BE870988A (fr) 1979-04-03
FR2405711A1 (fr) 1979-05-11
SE8107592L (sv) 1981-12-17
PT68600A (en) 1978-10-01
US4441609A (en) 1984-04-10

Similar Documents

Publication Publication Date Title
SE7810591L (sv) Farmaceutiska kompositioner
FI783917A (fi) Aminderivat deras framstaellningsfoerfarande och dessa innehaollande farmaceutiska kompositioner
SE7806691L (sv) Ostomikomposition
BE872319A (fr) Composition pharmaceutique
AR219293A1 (es) Composiciones de poliester-poliimida
RO78326A (ro) Compozitie erbicida
SE7711395L (sv) Farmaceutisk komposition
BE864359A (fr) Compositions pharmaceutiques antioestrogenes
IT1095377B (it) Composizione farmaceutica
SE7801529L (sv) Pesticid komposition
SE7803941L (sv) Antioxiderande kompositioner
FI783796A (fi) Faergframkallande komposition
RO85275A (ro) Compozitie mildincida
IT7867018A0 (it) Composizione antiulcera
SE7803128L (sv) Mikrobicid komposition
IT7849938A0 (it) Composizioni farmaceutiche
SE7801368L (sv) Pesticid komposition
SE7801194L (sv) Cerealiekomposition
SE7806441L (sv) Lekemedelskomposition
SE7801430L (sv) Pepsticid komposition
FI773882A (fi) Komposition
SE7807376L (sv) Kompositioner
IT1101681B (it) Composizione funcicida
FI781435A (fi) Fungicid komposition
NL7801464A (nl) Farmaceutische samenstellingen.

Legal Events

Date Code Title Description
SPCF Application for supplementary protection certificate filed

Free format text: 7810591

NAL Patent in force

Ref document number: 7810591-3

Format of ref document f/p: F

SPCG Supplementary protection certificate granted

Free format text: 9490106, 871211, EXPIRES: 20021210

NUG Patent has lapsed

Ref document number: 7810591-3

Format of ref document f/p: F